相似文献
1
Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers.
Indian J Med Res. 2020;152(1 & 2):119-120. doi: 10.4103/ijmr.IJMR_2372_20.
2
Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
Indian J Med Res. 2020;152(1 & 2):116-118. doi: 10.4103/ijmr.IJMR_2396_20.
3
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
N Engl J Med. 2020 Sep 10;383(11):1087-1088. doi: 10.1056/NEJMc2023617. Epub 2020 Jul 15.
4
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
N Engl J Med. 2020 Sep 10;383(11):1088. doi: 10.1056/NEJMc2023617. Epub 2020 Jul 15.
5
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
N Engl J Med. 2020 Sep 10;383(11):1088-1089. doi: 10.1056/NEJMc2023617. Epub 2020 Jul 15.
6
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
N Engl J Med. 2020 Sep 10;383(11):1089. doi: 10.1056/NEJMc2023617. Epub 2020 Jul 15.
7
Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.
Lancet Infect Dis. 2020 Oct;20(10):1119-1120. doi: 10.1016/S1473-3099(20)30430-8. Epub 2020 May 22.
8
Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen.
Indian J Med Res. 2020;152(1 & 2):130-132. doi: 10.4103/ijmr.IJMR_3077_20.
9
Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019?
Clin Infect Dis. 2020 Jul 28;71(15):887-888. doi: 10.1093/cid/ciaa320.
10
Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
Clin Infect Dis. 2020 Jul 28;71(15):888-889. doi: 10.1093/cid/ciaa321.
引用本文的文献
1
Managing rheumatoid arthritis during COVID-19.
Clin Rheumatol. 2020 Nov;39(11):3237-3244. doi: 10.1007/s10067-020-05358-z. Epub 2020 Sep 6.
2
Risks of hydroxychloroquine use for COVID-19 prophylaxis.
J Am Acad Dermatol. 2020 Jul;83(1):e73-e74. doi: 10.1016/j.jaad.2020.04.111. Epub 2020 Apr 26.
本文引用的文献
1
Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.
Indian J Med Res. 2020 May;151(5):459-467. doi: 10.4103/ijmr.IJMR_2234_20.
2
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
3
Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
Lancet Infect Dis. 2020 Oct;20(10):1118-1119. doi: 10.1016/S1473-3099(20)30313-3. Epub 2020 Apr 17.
4
Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?
Int J Antimicrob Agents. 2020 Jun;55(6):105988. doi: 10.1016/j.ijantimicag.2020.105988. Epub 2020 Apr 17.
Zotero 插件